Brazilian pharmaceutical company Hypera said on Thursday it expects 1.7 billion reais ($331.83 million) in net income for 2022.

Brazilian drugmaker Hypera SA is in talks to merge with conglomerate Grupo NC, according to a Tuesday report from business newspaper Valor Economico.

Clever Leaves Holdings Inc. CLVR CLVRW has entered into a five-year agreement with Hypera Pharma (B3:HYPE3) to supply Clever Leaves’ CBD-dominant oral solutions with the aim of treating various ...

SAO PAULO (Reuters) - Brazil's Hypera Pharma said on Monday that it has signed a contract to buy a portfolio of 18 products from Japan's Takeda Pharmaceutical Co for $825 million. Shares in Hypera ...

Brazil's Hypera Pharma said on Monday that it has signed a contract to buy a portofolio of 18 pharmaceutical products from Japan's Takeda for $825 million. Skip to main content.